Stock Track | Celestica Soars 5.24% on Strong Q2 Results, Analyst Upgrades, and Board Appointment

Stock Track
30 Jul

Celestica Inc. (CLS) shares are soaring 5.24% in pre-market trading on Wednesday, following a series of positive developments for the electronics manufacturing services company. The stock's surge comes on the heels of impressive second-quarter results, multiple analyst price target upgrades, and the announcement of a new board member.

Celestica reported its strongest beat and raise in more than two years, driven by robust demand from hyperscalers. This performance prompted several analysts to revise their outlook on the company. RBC Capital Markets raised its price target to US$225 from US$185, maintaining an Outperform rating. Analyst Paul Treiber noted, "Even though the shares have materially re-rated upwards, we see Celestica's valuation premium being sustained in light of strong growth and improved revenue mix." Other firms including Argus Research, BMO, JP Morgan, and Citigroup also significantly increased their price targets, with most now ranging between $212 and $230.

Adding to the positive momentum, Celestica announced the appointment of Chris Colpitts to its Board of Directors. Mr. Colpitts brings 20 years of extensive experience in the technology, media, and telecommunications sectors, which is expected to provide valuable guidance as the company navigates its next phase of innovation and expansion. This strategic move further bolsters investor confidence in Celestica's growth trajectory and corporate governance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10